Surgery Websites
Thoracic Oncology Program »  Meet the Team »  Medical Oncologists »  Ross Okimoto, M.D.
Ross Okimoto, M.D.

Ross Okimoto, M.D.

Clinical Instructor

Open Popup

Creighton University School of Medicine 2009

  • Tufts Medical Center, Internal Medicine 2012
  • UCSF Medical Center, Medical Oncology 2014
  • American Board of Internal Medicine
  • American Board of Internal Medicine, Medical Oncology

Dr. Ross Okimoto is a medical oncologist specializing in the care of adult patients with soft tissue and bone sarcomas. He works with a team of surgeons, radiation oncologists and pathologists to provide the best possible outcomes for his patients.

Okimoto attended Creighton University School of Medicine. He completed his internal medicine residency training at Tufts Medical Center in Boston and his medical oncology fellowship at UCSF.

Data provided by UCSF Profiles, powered by CTSI at UCSF
  • American Society of Clinical Investigation Young Physician-Scientist Award, 2019
  • NIH-NCI Career Development Award (K08), 2018-2023
  • UCSF DOM Cohort Iniative Award, 2018
  • A.P. Giannini Postdoctoral Fellowship, 2015

A physician-scientist, Okimoto conducts research in addition to providing clinical care. The overall goal of his laboratory-based investigations is to help improve outcomes for cancer patients. His current research work focuses on understanding the molecular mechanisms that promote tumor cell metastasis.

Data provided by UCSF Profiles, powered by CTSI
  • Therapeutic rescue of the transcriptional repressor Capicua to inhibit lung cancer metastasis
    Sponsor ID:
    Funding Period:
    Feb 2018
    Jan 2023
    Principal Investigator
Data provided by UCSF Profiles, powered by CTSI
  1. Okimoto RA, Wu W, Nanjo S, Olivas V, Lin YK, Ponce RK, Oyama R, Kondo T, Bivona TG. CIC-DUX4 oncoprotein drives sarcoma metastasis and tumorigenesis via distinct regulatory programs. J Clin Invest. 2019 07 22; 129(8):3401-3406. View in PubMed
  2. Fish L, Navickas A, Culbertson B, Xu Y, Nguyen HCB, Zhang S, Hochman M, Okimoto R, Dill BD, Molina H, Najafabadi HS, Alarcón C, Ruggero D, Goodarzi H. Nuclear TARBP2 Drives Oncogenic Dysregulation of RNA Splicing and Decay. Mol Cell. 2019 09 05; 75(5):967-981.e9. View in PubMed
  3. Okimoto RA, Bivona TG. Metastasis: From head to tail. Cell Cycle. 2017 03 19; 16(6):487-488. View in PubMed
  4. Okimoto RA, Breitenbuecher F, Olivas VR, Wu W, Gini B, Hofree M, Asthana S, Hrustanovic G, Flanagan J, Tulpule A, Blakely CM, Haringsma HJ, Simmons AD, Gowen K, Suh J, Miller VA, Ali S, Schuler M, Bivona TG. Inactivation of Capicua drives cancer metastasis. Nat Genet. 2017 01; 49(1):87-96. View in PubMed
  5. Okimoto RA, Lin L, Olivas V, Chan E, Markegard E, Rymar A, Neel D, Chen X, Hemmati G, Bollag G, Bivona TG. Preclinical efficacy of a RAF inhibitor that evades paradoxical MAPK pathway activation in protein kinase BRAF-mutant lung cancer. Proc Natl Acad Sci U S A. 2016 11 22; 113(47):13456-13461. View in PubMed
  6. View All Publications


Site Directory